down arrow

Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
120.00
3.55 (3.05%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.46 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Bliss GVS Pharma Ltd stock-summary
stock-summary
Bliss GVS Pharma Ltd
Small Cap
Pharmaceuticals & Drugs
Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006.
Company Coordinates stock-summary
Company Details
102 Hyde Park Sakivihar Road, Andheri East Mumbai Maharashtra : 400072
stock-summary
Tel: 91-22-42160000
stock-summary
http://www.blissgvs.com
stock-summary
info@blissgvs.com
Registrar Details
Mondkar Computers Pvt Ltd , 21 Shakil Niwas , Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.51 Cr
Number of Shares
10.51 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
12-Sep-2024
10.51
10.51
114750
1
Issued under ESOP Scheme
14-Aug-2024
10.5
10.50
64150
1
Issued under ESOP Scheme
09-Jul-2024
10.5
10.50
83000
1
Issued under ESOP Scheme
10-Jun-2024
10.49
10.49
145000
1
Issued under ESOP Scheme
15-May-2024
10.47
10.47
46750
1
Issued under ESOP Scheme
16-Jan-2024
10.47
10.47
18000
1
Issued under ESOP Scheme
09-Oct-2023
10.47
10.47
274150
1
Issued under ESOP Scheme
29-Aug-2023
10.44
10.44
117750
1
Issued under ESOP Scheme
26-Jul-2023
10.43
10.43
57750
1
Issued under ESOP Scheme
23-Jun-2023
10.42
10.42
26000
1
Issued under ESOP Scheme
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 42 FIIs (13.51%)

Promoter with highest holding

Narsimha Shibroor Kamath (30.69%)

Highest Public shareholder

Arian Investment Limited (8.76%)

Individual Investors Holdings

32.93%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Vibha G Sharma
Whole-time Director
70.49 lacs
Shruti Vishal Rao
Whole-time Director
67.33 lacs
Subramanian R Vaidya
Chairman & Independent Directo
3.75 lacs
Santosh Parab
Non-Exec. & Independent Dir.
3.75 lacs
Aditi Bhatt
Company Sec. & Compli. Officer
0
Shilpa Bhatia
Non-Exec. & Independent Dir.
3.75 lacs
Gagan Harsh Sharmma
Managing Director
1.8 cr
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
210 Cr
(Quarterly Results - Dec 2024)
Net Profit:
24 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,264 Cr (Small Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.43%

stock-summary
Debt Equity

-0.12

stock-summary
Return on Equity

9.17%

stock-summary
Price to Book

1.22

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."